| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accounting for dropout in xenografted tumour efficacy studies: integrated endpoint analysis, reduced bias and better use of animals
|
Martin, Emma C.
|
|
2016
|
78 |
1 |
p. 131-141
|
artikel
|
| 2 |
A clinical drug–drug interaction study to evaluate the effect of a proton-pump inhibitor, a combined P-glycoprotein/cytochrome 450 enzyme (CYP)3A4 inhibitor, and a CYP2C9 inhibitor on the pharmacokinetics of vismodegib
|
Malhi, Vikram
|
|
2016
|
78 |
1 |
p. 41-49
|
artikel
|
| 3 |
A phase I study of mTOR inhibitor everolimus in association with cisplatin and radiotherapy for the treatment of locally advanced cervix cancer: PHOENIX I
|
Melo, Andréia Cristina de
|
|
2016
|
78 |
1 |
p. 101-109
|
artikel
|
| 4 |
A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma
|
Satake, Hironaga
|
|
2016
|
78 |
1 |
p. 91-99
|
artikel
|
| 5 |
Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials
|
Bilen, Mehmet Asim
|
|
2016
|
78 |
1 |
p. 167-171
|
artikel
|
| 6 |
Atrial natriuretic peptide protects against cisplatin-induced granulocytopenia
|
Nojiri, Takashi
|
|
2016
|
78 |
1 |
p. 191-197
|
artikel
|
| 7 |
Benefit of uridine triacetate (Vistogard) in rescuing severe 5-fluorouracil toxicity in patients with dihydropyrimidine dehydrogenase (DPYD) deficiency
|
Saif, Muhammad Wasif
|
|
2016
|
78 |
1 |
p. 151-156
|
artikel
|
| 8 |
Chronomodulated oxaliplatin plus Capecitabine (XELOX) as a first line chemotherapy in metastatic colorectal cancer: A Phase II Brunch regimen study
|
Pilancı, Kezban Nur
|
|
2016
|
78 |
1 |
p. 143-150
|
artikel
|
| 9 |
Clinical and pharmacologic evaluation of two dosing schedules of indotecan (LMP400), a novel indenoisoquinoline, in patients with advanced solid tumors
|
Kummar, Shivaani
|
|
2016
|
78 |
1 |
p. 73-81
|
artikel
|
| 10 |
Combinational strategies of metformin and chemotherapy in cancers
|
Zhang, Hui-Hui
|
|
2016
|
78 |
1 |
p. 13-26
|
artikel
|
| 11 |
Developing more effective, non-neurotoxic, methotrexate-based therapy in infants with brain tumors
|
Cohen, Ian J.
|
|
2016
|
78 |
1 |
p. 217-218
|
artikel
|
| 12 |
Effect of renal function on pemetrexed-induced haematotoxicity
|
Ando, Yosuke
|
|
2016
|
78 |
1 |
p. 183-189
|
artikel
|
| 13 |
Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation
|
Yamashita, Takaya
|
|
2016
|
78 |
1 |
p. 111-118
|
artikel
|
| 14 |
Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia–lymphoma and peripheral T-cell lymphoma
|
Ogura, Michinori
|
|
2016
|
78 |
1 |
p. 199-207
|
artikel
|
| 15 |
Everolimus pharmacokinetics and its exposure–toxicity relationship in patients with thyroid cancer
|
Wit, D. de
|
|
2016
|
78 |
1 |
p. 63-71
|
artikel
|
| 16 |
Gibberellin derivative GA-13315 sensitizes multidrug-resistant cancer cells by antagonizing ABCB1 while agonizes ABCC1
|
Mo, Jiao
|
|
2016
|
78 |
1 |
p. 51-61
|
artikel
|
| 17 |
Methotrexate-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses
|
Campbell, Jared M.
|
|
2016
|
78 |
1 |
p. 27-39
|
artikel
|
| 18 |
Monte Carlo simulations of the clinical benefits from therapeutic drug monitoring of sunitinib in patients with gastrointestinal stromal tumours
|
Goulooze, Sebastiaan C.
|
|
2016
|
78 |
1 |
p. 209-216
|
artikel
|
| 19 |
Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective
|
Ciccolini, Joseph
|
|
2016
|
78 |
1 |
p. 1-12
|
artikel
|
| 20 |
Pharmacokinetics and safety of vitamin E δ-tocotrienol after single and multiple doses in healthy subjects with measurement of vitamin E metabolites
|
Mahipal, Amit
|
|
2016
|
78 |
1 |
p. 157-165
|
artikel
|
| 21 |
Pharmacokinetics, safety, and efficacy of lenalidomide plus dexamethasone in patients with multiple myeloma and renal impairment
|
Bridoux, Frank
|
|
2016
|
78 |
1 |
p. 173-182
|
artikel
|
| 22 |
Phase I safety and pharmacokinetic dose-escalation study of pilaralisib polymorph E, a phosphoinositide 3-kinase inhibitor in tablet formulation, in patients with solid tumors or lymphoma
|
Bechter, Oliver E.
|
|
2016
|
78 |
1 |
p. 83-90
|
artikel
|
| 23 |
Reply to Prof Ian J. Cohen
|
Lucchesi, Maurizio
|
|
2016
|
78 |
1 |
p. 219-220
|
artikel
|
| 24 |
RETRACTED ARTICLE: Atrial natriuretic peptide protects against cisplatin-induced granulocytopenia
|
Nojiri, Takashi
|
|
|
78 |
1 |
p. 191-197
|
artikel
|
| 25 |
UGT1A1 gene polymorphism is associated with toxicity and clinical efficacy of irinotecan-based chemotherapy in patients with advanced colorectal cancer
|
Xu, Chunlei
|
|
2016
|
78 |
1 |
p. 119-130
|
artikel
|
Tijdschrift beschrijving